PMID- 15526506
OWN - NLM
STAT- MEDLINE
DCOM- 20041209
LR  - 20161124
IS  - 1220-4749 (Print)
IS  - 1220-4749 (Linking)
VI  - 41
IP  - 3
DP  - 2003
TI  - Restenosis in the coronary stent is an argument for the surgical myocardial 
      revascularization.
PG  - 227-35
AB  - BACKGROUND: This study will evaluate the difference between the frequency of 
      restenosis in myocardial revascularization procedures by stents and CABG by 
      coronarographic control after clinical criteria (angina). METHODS AND RESULTS: 
      Out of the total of 6564 coronarographies performed (1999-2002) for diagnosis 
      purposes, 3110 patients (44.8%) underwent myocardial revascularization 
      procedures, PCI or CABG. PCI was performed in 981 patients (31%) and CABG in 1148 
      patients (37.3%). At the same time, we performed in our units 2067 surgical 
      procedures, out of which 1148 (55%) revascularizations by CABG. The angiographic 
      control for patients with myocardial revascularization by stent (55 patients) or 
      CABG (50 patients) was performed by clinical criteria (angina reappears) on 105 
      patients. The restenosis we found in 47 patients (74.5%) treated by stent 
      revascularization and in 29 patients from CABG procedures. In our study 
      restenosis rate was 4.8% in patients with PCI and 2.5% in patients with CABG. 
      CONCLUSIONS: Both surgical (CABG) and percutaneous coronary artery 
      revascularization (PCI) have proved to be extremely effective in the treatment of 
      patients with multivessel coronary disease. In our study restenosis rate was 
      smaller in the patients with CABG than in the PCI group, taking into account the 
      fact that we did not use drug eluting stent (DES) on a large scale. Results from 
      the series of randomized trials (SOS, SIRIUS, ERACI, ARTS, BARI, etc.) have shown 
      that the restenosis phenomenon is an apparent advantage in patients with DES. 
      Restenosis prevention is a complex phenomenon (inflammation, procoagulation, 
      cellular migration, etc.) and DES appearance opens a new era in PCI.
FAU - Goleanu, V
AU  - Goleanu V
FAU - Tintoiu, I
AU  - Tintoiu I
FAU - Iacob, M
AU  - Iacob M
FAU - Pinte, Florina
AU  - Pinte F
FAU - Gafencu, M
AU  - Gafencu M
FAU - Mocanu, I
AU  - Mocanu I
FAU - Mustata, D
AU  - Mustata D
FAU - Droc, I
AU  - Droc I
FAU - Dumitrascu, Gh
AU  - Dumitrascu G
FAU - Greere, V
AU  - Greere V
FAU - Neagoe, Gh
AU  - Neagoe G
FAU - Lazar, O
AU  - Lazar O
FAU - Labont, Beatris
AU  - Labont B
FAU - Teodorescu, Andreea
AU  - Teodorescu A
FAU - Ravescu, Manuela
AU  - Ravescu M
FAU - Trandafir, D
AU  - Trandafir D
LA  - eng
PT  - Journal Article
PL  - Germany
TA  - Rom J Intern Med
JT  - Romanian journal of internal medicine = Revue roumaine de medecine interne
JID - 9304507
SB  - IM
MH  - Angina Pectoris/etiology
MH  - Angioplasty, Balloon, Coronary/*adverse effects
MH  - Blood Vessel Prosthesis Implantation/*adverse effects
MH  - Coronary Angiography
MH  - Coronary Artery Bypass/*adverse effects
MH  - Coronary Restenosis/diagnostic imaging/epidemiology/*etiology
MH  - Humans
MH  - Myocardial Revascularization/adverse effects
MH  - Prevalence
MH  - Stents/adverse effects
EDAT- 2004/11/06 09:00
MHDA- 2004/12/16 09:00
CRDT- 2004/11/06 09:00
PHST- 2004/11/06 09:00 [pubmed]
PHST- 2004/12/16 09:00 [medline]
PHST- 2004/11/06 09:00 [entrez]
PST - ppublish
SO  - Rom J Intern Med. 2003;41(3):227-35.